Efamol Limited
🏢 View company profile →35Patents
0Active
35Granted
35Portfolio score
Filing activity: Jan 19, 1979 → Mar 6, 1996
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4666701A | Pharmaceutical and dietary compositions | Human Necessities | 62 | Expired |
| US4826877A | Pharmaceutical and dietary composition | Human Necessities | 62 | Expired |
| US4444755A | Treatment for skin disorders | Human Necessities | 61 | Expired |
| US4758592A | Method of treating or preventing endometriosis | Human Necessities | 56 | Expired |
| US4681896A | Pharmaceutical and dietary composition | Human Necessities | 46 | Expired |
| US4388324A | Pharmaceutical and dietary composition | Human Necessities | 39 | Expired |
| US4302447A | Pharmaceutical and dietary composition | Human Necessities | 36 | Expired |
| US4273763A | Pharmaceutical and dietary compositions | Human Necessities | 36 | Expired |
| US4888326A | Method of treating defective T-lymphocyte function with rutin or troxerutin in combination with .gamma.-linolenic acid or dihomo-.gamma.-linolenic acid | Human Necessities | 36 | Expired |
| US5145686A | Topical pharmaceutical compositions | Human Necessities | 31 | Expired |
| US4415554A | Treatment for menstrual disorders | Human Necessities | 28 | Expired |
| US4393049A | Treatment for obesity | Human Necessities | 22 | Expired |
| US4965075A | Methods of increasing 1-series PGs in the body | Human Necessities | 22 | Expired |
| US4996233A | Method of reducing porphyrin toxicity using fatty acids | Human Necessities | 21 | Expired |
| US5324748A | Method for enhancement of 1-series PG production | Human Necessities | 21 | Expired |
| US4837221A | Methods of treating tumors susceptible to necrosis | Chemistry; Metallurgy | 21 | Expired |
| US4810497A | Pharmaceutical compositions | Human Necessities | 20 | Expired |
| US4898885A | Pharmaceutica and dietary compositions | Human Necessities | 20 | Expired |
| US5246726A | Iron-containing composition and method for treatment of cancer | Human Necessities | 17 | Expired |
| US5589509A | Methods of reducing porphyrin toxicity using fatty acids | Human Necessities | 15 | Expired |
| US4868212A | Pharmaceutical and dietary composition | Human Necessities | 11 | Expired |
| US4753964A | Pharmaceutical compositions of lithium compounds to treat presenile or senile dementia | Human Necessities | 11 | Expired |
| US4738853A | Food production | Emerging Cross-Sectional Technologies | 10 | Expired |
| US4806569A | Pharmaceutical and dietary composition | Human Necessities | 8 | Expired |
| US4764532A | Treatment of horses | Human Necessities | 7 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.